The Jianpi Antai formula can safely enhance embryo implantation, decrease the embryo miscarriage rate, and increase the live birth rate in infertile women undergoing in-vitro fertilization.
Three hundred infertile women, undergoing two frozen embryo transfer procedures at the Reproductive Medicine Center, Sir Run Run Shaw Hospital, were randomly split into a study and control group. The study group was administered both routine medication and Jianpi Antai formula during the period of embryo transfer while the control group received only routine medication. Factors such as the general health condition of the women, the embryo implantation rate, clinical pregnancy rate, live birth rate, and routine blood and function of liver and kidney were evaluated and compared between both groups.
Upon completion of the study, an observed 277 cases, which consisted of 134 participants in the study group and 143 in the control group, indicated higher rates of embryo implantation, clinical pregnancy, and live birth rates in the study group. A subgroup analysis further revealed that patients of an older age and those with reduced ovarian reserve functions also had higher rates in the aforementioned factors within the study group as compared to the control group. Throughout the follow-up period, neither group reported any abnormalities in their basic vital signs or any adverse events.
